<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[aaiPharma Inc. | Company News & Executive Profiles | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/aaipharma+inc..html?i=8]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for aaiPharma Inc.]]></description>
	<s:counts start="0" returned="2" found="2" />
	<language>en-us</language>
	<item>
		<title><![CDATA[aaiPharma Regains Nasdaq Listing Compliance; Ticker Symbol to Revert to AAII on Friday, July 9, 2004]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_July_8/ai_n6099653]]></link>
		<description><![CDATA[WILMINGTON, N.C. -- aaiPharma Inc. (Nasdaq: AAIIE) announced today that it has received notification from Nasdaq that the Company has evidenced compliance with the current requirements necessary for continued listing on The Nasdaq National Market. Effective with the open of business on Friday, July 9, 2004 the Company's ticker symbol...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 08 Jul 2004 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aaipharma+inc..html"><![CDATA[aaiPharma Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[University of North Carolina signs technology transfer agreement with aaiPharma.(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6487/is_200209/ai_n25823406]]></link>
		<description><![CDATA[The University of North Carolina at Wilmington (Wilmington, NC)  announced that it has signed its first-ever technology-transfer  licensing agreement with aaiPharma, Inc.  The agreement is expected to  facilitate the transfer of scientific discoveries by university  researchers into future useful medicines.    Although actual...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 01 Sep 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aaipharma+inc..html"><![CDATA[aaiPharma Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/biology.html"><![CDATA[biology]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+north+carolina.html"><![CDATA[University of North Carolina]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
